-
AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Acclarent
Discussion in 'Acclarent' started by Anonymous, Dec 7, 2010 at 4:36 PM.
Page 194 of 194
Page 194 of 194